RECKITT BENCKIS/S (OTCMKTS:RBGLY) Rating Reiterated by Berenberg Bank
Berenberg Bank reissued their buy rating on shares of RECKITT BENCKIS/S (OTCMKTS:RBGLY) in a report published on Friday morning, The Fly reports.
A number of other equities research analysts also recently weighed in on RBGLY. Morgan Stanley reissued an overweight rating on shares of RECKITT BENCKIS/S in a report on Monday, June 15th. UBS Group upgraded RECKITT BENCKIS/S from a neutral rating to a buy rating in a research report on Monday, June 29th. Zacks Investment Research upgraded RECKITT BENCKIS/S from a hold rating to a buy rating and set a $18.00 price target on the stock in a research report on Thursday, May 7th. Barclays restated an overweight rating on shares of RECKITT BENCKIS/S in a research report on Tuesday, June 23rd. Finally, Jefferies Financial Group upgraded RECKITT BENCKIS/S from an underperform rating to a hold rating in a research report on Wednesday, March 18th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average target price of $18.00.
Shares of RECKITT BENCKIS/S stock opened at $19.69 on Friday. The business has a fifty day simple moving average of $18.04 and a two-hundred day simple moving average of $16.60. RECKITT BENCKIS/S has a 1 year low of $12.76 and a 1 year high of $19.77. The company has a market capitalization of $69.84 billion, a price-to-earnings ratio of 21.88 and a beta of 0.71. The company has a debt-to-equity ratio of 0.91, a current ratio of 0.56 and a quick ratio of 0.42.
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.
Read More: Understanding Price to Earnings Ratio (PE)
Receive News & Ratings for RECKITT BENCKIS/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RECKITT BENCKIS/S and related companies with MarketBeat.com's FREE daily email newsletter.